Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic

dc.contributor.authorSimmons, D.
dc.contributor.authorRudland, V.L.
dc.contributor.authorWong, V.
dc.contributor.authorFlack, J.
dc.contributor.authorMackie, A.
dc.contributor.authorRoss, G.P.
dc.contributor.authorCoat, S.
dc.contributor.authorDalal, R.
dc.contributor.authorHague, B.M.
dc.contributor.authorCheung, N.W.
dc.date.issued2020
dc.description.abstractThe balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24–28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a onehour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L: misses 44–54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7–5.0 mmol/L (62–72% sensitive)). Choices should emphasise local and patient decision-making.
dc.description.statementofresponsibilityDavid Simmons, Victoria L. Rudland, Vincent Wong, Jeff Flack, Adam Mackie, Glynis P. Ross, Suzette Coat, Raiyomand Dalal, Bill M. Hague, and Ngai Wah Cheung
dc.identifier.citationAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2020; 60(5):660-666
dc.identifier.doi10.1111/ajo.13224
dc.identifier.issn0004-8666
dc.identifier.issn1479-828X
dc.identifier.orcidCoat, S. [0000-0002-3836-2854]
dc.identifier.orcidHague, B.M. [0000-0002-5355-2955]
dc.identifier.urihttps://hdl.handle.net/2440/145923
dc.language.isoen
dc.publisherWiley
dc.rights© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists
dc.source.urihttps://doi.org/10.1111/ajo.13224
dc.subjectdiagnosis; gestational diabetes mellitus; macrosomia; screening; stillbirth
dc.subject.meshHumans
dc.subject.meshPregnancy Complications, Infectious
dc.subject.meshPneumonia, Viral
dc.subject.meshCoronavirus Infections
dc.subject.meshDiabetes, Gestational
dc.subject.meshBlood Glucose
dc.subject.meshGlucose Tolerance Test
dc.subject.meshPrenatal Diagnosis
dc.subject.meshPregnancy Outcome
dc.subject.meshPatient Isolation
dc.subject.meshRisk Assessment
dc.subject.meshInfection Control
dc.subject.meshGestational Age
dc.subject.meshPregnancy
dc.subject.meshAdult
dc.subject.meshFemale
dc.subject.meshPandemics
dc.subject.meshClinical Decision-Making
dc.subject.meshCOVID-19
dc.titleOptions for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections